Assessment of the effectiveness of the ReAttach Protocol for Oncology Patients with the Symptom Amplification Model? A study protocol.
Published 2025-11-25
Keywords
- Oncology,
- ReAttach,
- OT,
- Symptom Amplification Model,
- Psychobiosocial Conditions
Copyright (c) 2025 Sieto Reitsma, Steven Painter, Dr. Paula Zeestraten-Bartholomeus, Prof. Dr. Aida Mehrad (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
Abstract
Oncology is a psychosocial condition that significantly affects both cancer patients and their families. A trans-diagnostic, multimodal approach, such as ReAttach therapy, may play a crucial role in the recovery from this complex condition by targeting underlying mechanisms and influencing the networks associated with persistent symptoms [1]. This is the first study protocol to assess the effectiveness of ReAttach therapy in oncology patients. The protocol outlines a prospective observational cohort study to evaluate the effectiveness of ReAttach therapy in this population, using the Symptom Amplification Model (SAM) and continuous real-world data collection via NeuroLog [2]. This protocol is part of a systematic research program that investigates ReAttach therapy across various psychobiosocial conditions (functional neurological disorder [3], post-concussion syndrome [4], oncology, fibromyalgia and Parkinson’s Disease).